Unknown

Dataset Information

0

Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.

ABSTRACT: AIMS:A 25-base pair deletion in the cardiac myosin binding protein-C (cMyBP-C) gene (MYBPC3), proposed to skip exon 33, modifies the C10 domain (cMyBP-C?C10mut) and is associated with hypertrophic cardiomyopathy (HCM) and heart failure, affecting approximately 100 million South Asians. However, the molecular mechanisms underlying the pathogenicity of cMyBP-C?C10mutin vivo are unknown. We hypothesized that expression of cMyBP-C?C10mut exerts a poison polypeptide effect leading to improper assembly of cardiac sarcomeres and the development of HCM. METHODS AND RESULTS:To determine whether expression of cMyBP-C?C10mut is sufficient to cause HCM and contractile dysfunction in vivo, we generated transgenic (TG) mice having cardiac-specific protein expression of cMyBP-C?C10mut at approximately half the level of endogenous cMyBP-C. At 12?weeks of age, significant hypertrophy was observed in TG mice expressing cMyBP-C?C10mut (heart weight/body weight ratio: 4.43?±?0.11?mg/g non-transgenic (NTG) vs. 5.34?±?0.25?mg/g cMyBP-C?C10mut, P?

SUBMITTER: Kuster DWD 

PROVIDER: S-EPMC6872972 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.

Kuster Diederik W D DWD   Lynch Thomas L TL   Barefield David Y DY   Sivaguru Mayandi M   Kuffel Gina G   Zilliox Michael J MJ   Lee Kyoung Hwan KH   Craig Roger R   Namakkal-Soorappan Rajasekaran R   Sadayappan Sakthivel S  

Cardiovascular research 20191201 14

<h4>Aims</h4>A 25-base pair deletion in the cardiac myosin binding protein-C (cMyBP-C) gene (MYBPC3), proposed to skip exon 33, modifies the C10 domain (cMyBP-CΔC10mut) and is associated with hypertrophic cardiomyopathy (HCM) and heart failure, affecting approximately 100 million South Asians. However, the molecular mechanisms underlying the pathogenicity of cMyBP-CΔC10mutin vivo are unknown. We hypothesized that expression of cMyBP-CΔC10mut exerts a poison polypeptide effect leading to improper  ...[more]

Similar Datasets

Unknown The hypertrophic cardiomyopathy myosin mutation R453C alters ATP binding and hydrolysis of human cardiac ?-myosin.
| S-EPMC3931073 | biostudies-literature
Unknown Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner.
| S-EPMC8239744 | biostudies-literature
Unknown Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy.
| S-EPMC2893345 | biostudies-literature
Unknown Cardiac myosin binding protein-C variants in paediatric-onset hypertrophic cardiomyopathy: natural history and clinical outcomes.
| S-EPMC7613139 | biostudies-literature
Unknown Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition.
| S-EPMC6167380 | biostudies-literature
Unknown Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy.
| S-EPMC3229838 | biostudies-literature
Unknown Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene.
| S-EPMC1051243 | biostudies-other
Unknown A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.
| S-EPMC508976 | biostudies-other
Unknown Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein.
| S-EPMC508212 | biostudies-other
Unknown Myosin-binding Protein C Compound Heterozygous Variant Effect on the Phenotypic Expression of Hypertrophic Cardiomyopathy.
| S-EPMC5421475 | biostudies-literature